Clinical Trial

Randomized Controlled Trial of the Effects of Combined Resistance and AerobiC Exercise on Health-related Quality of Life in Patients Undergoing First-line Chemotherapy for Metastatic Colorectal Cancer (REACH)

Study acronym: REACH
Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of this trial is to compare the effects of 18 weeks structured exercise training versus on control on healt-related quality of life in patients with mCRC undergoing first-line chemotherapy.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-04-14; most recent amendment 2026-05-08.
Status change: Not Yet Recruiting → Recruiting 2025-05-21
Trial Details
NCT Number NCT06938971
Lead Sponsor Rigshospitalet, Denmark
Conditions Metastatic Colorectal Cancer (mCRC)
Enrollment 150 participants
Start Date 2025-05-16
Primary Completion 2027-05-01 (estimated)
Study Completion 2030-05-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-13